Suven Life Sciences Ltd share price logo

Suven Life Sciences Ltd Share Price

(SUVEN)

₹142.579.58%

as on 11:28AM, 24 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Suven Performance

  • Day's Low

    Day's High

    ₹130.5
    Day's Price Range
    ₹143.35
  • 52 Week's Low

    52 Week's High

    ₹82.95
    52-Week Price Range
    ₹169.3
1 Month Return+ 3.96 %
3 Month Return+ 7.46 %
1 Year Return+ 15.7 %
Previous Close₹130.10
Open₹141.70
Volume7.70L
Upper Circuit₹156.12
Lower Circuit₹104.08
Market Cap₹2,837.14Cr

Suven Fundamentals

P/E Ratio

-19.8

PEG Ratio

11

Market Cap

₹2,837.14 Cr

P/B Ratio

2.57

EPS

-4.82

Dividend Yield

0

Sector

Healthcare

ROE

-2.36

Mutual Fund Holdings of Suven

Key events for Suven Life Sciences Ltd

  • Venkat Jasti's Bold Investment in CNS Drug Development - 02 Apr, 2025

    Venkat Jasti of Suven Life Sciences is investing heavily in CNS drug development, having sold his CDMO business for Rs 6,313 crore. Despite setbacks, he aims for breakthroughs with multiple drugs in clinical trials, including SUVN-502 for Alzheimer's and SUVN-G3031 for narcolepsy. The company has invested nearly Rs 3,000 crore in drug discovery, focusing on high-quality trials in the US.

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -49.64 Cr → -39.12 Cr (in ₹), with an average increase of 26.9% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.34% to 29.47% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SUVEN stock has moved up by 7.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.27% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.9% return, outperforming this stock by 93.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 55.3% return, outperforming this stock by 39.6%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.05% to 0.01% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.61 Cr → 3.24 Cr (in ₹), with an average decrease of 51.0% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.34% to 0.25% in Mar 2025 quarter

Suven Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹2.45Cr (-)₹2.39Cr (↓2.45%)₹1.01Cr (↓57.74%)₹2.57Cr (↑154.46%)₹1.61Cr (↓37.35%)
Net Income-₹41.76Cr (-)-₹26.54Cr (↓36.45%)-₹28.04Cr (↑5.65%)-₹49.64Cr (↑77.03%)-₹39.12Cr (↓21.19%)
Net Profit Margin-1,704.49% (-)-1,110.46% (↓34.85%)-2,776.24% (↑150.01%)-1,931.52% (↓30.43%)-2,429.81% (↑25.80%)
Value in ₹ crore
Details2021202220232024
Total Assets₹415.38Cr (-)₹486.35Cr (↑17.09%)₹860.44Cr (↑76.92%)₹851.48Cr (↓1.04%)
Total Liabilities₹13.72Cr (-)₹10.37Cr (↓24.42%)₹6.99Cr (↓32.59%)₹6.10Cr (↓12.73%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹45.15Cr (-)-₹36.68Cr (↓18.76%)-₹36.62Cr (↓0.16%)-₹22.92Cr (↓37.41%)-₹20.56Cr (↓10.30%)

Suven Index Inclusions

BSE Healthcare

₹43,008.69

0.74 (315.68%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹49,467.59

0.4 (194.95%)

Suven Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.27%
0.00
Foreign Institutions
0.25%
0.00
Mutual Funds
0.01%
0.00
Retail Investors
29.47%
0.00
Others
0%
0.00

Suven Key Indicators

Details20202021202220232024
Earning Per Share (₹)-6.82-5.22-7.73-5.42-4.82
Details20202021202220232024
Return On Equity %-3.48-5.73-9.17-4.2-2.36
Details20202021202220232024
Return On Assets %-22.94-17.37-25.08-13.75-12.34
Details20202021202220232024
Book Value Per Share (₹)10.385.146.0917.2112.38

Suven Valuation

Suven in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-19.80x)

April 23, 2025

Industry (104.10x)

April 23, 2025

Highest (-6.67x)

March 27, 2023

LowHigh

Suven Earnings and Dividends

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit jumped 6.32% since last year same period to ₹-39.12Cr in the Q3 2024-2025. On a quarterly growth basis, Suven Life Sciences Ltd has generated 21.19% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.15%.

    Read More about Dividends

Suven Technicals Summary

Bearish

Neutral

Bullish

Bullish

Suven Life Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.

Suven Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹2,837.14 Cr48.56%0.50-₹106 Cr₹11 Cr
NA₹353.91 Cr13.27%1.56-₹130 Cr₹404 Cr
BUY₹8,972.66 Cr9.3%0.58₹128 Cr₹1,207 Cr
NA₹138.92 Cr37.34%0.51NANA
BUY₹30,156.06 Cr28.87%0.56₹510 Cr₹3,488 Cr

About Suven

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Revenue: ₹1.61Cr as on December 2024 (Q4 24)
Net Profit: ₹-39.12Cr as on December 2024 (Q4 24)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven
HeadquartersHyderabad
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Suven Life Sciences Ltd

What is Suven Life Sciences Ltd price today?

Suven Life Sciences Ltd share price today stands at ₹142.57, Open: ₹141.7, Previous Close: ₹130.1, High: ₹143.35, Low: ₹130.5, 52 Week High: ₹169.3, 52 Week Low: ₹82.95.

How to Buy Suven Life Sciences Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Suven Life Sciences Ltd shares

What are today's traded volumes of Suven Life Sciences Ltd?

Today's traded volume of Suven Life Sciences Ltd(SUVEN) is 7.70L.

What is today's market capitalisation of Suven Life Sciences Ltd?

Today's market capitalisation of Suven Life Sciences Ltd(SUVEN) is ₹2837.14Cr.

What is the 52 Week High and Low Range of Suven Life Sciences Ltd?

Suven Life Sciences Ltd (SUVEN)
Price
52 Week High
₹169.3
52 Week Low
₹82.95

How much percentage Suven Life Sciences Ltd is down from its 52 Week High?

Suven Life Sciences Ltd (SUVEN) share price is ₹142.57. It is down -15.79% from its 52 Week High price of ₹169.3

How much percentage Suven Life Sciences Ltd is up from its 52 Week low?

Suven Life Sciences Ltd (SUVEN) share price is ₹142.57. It is up 71.87% from its 52 Week Low price of ₹82.95